Lilly also has tirzepatide (Mounjaro), a dual GIP and GLP-1 RA, which is demonstrating significant efficacy in glucose control and weight loss and poses a considerable competitive threat
Growth in personalized medicine approaches The upsurge in personalized medicine approaches is making a bunch of very real opportunities within the global market for GLP-1 agonists
Proper storage and handling of peptides significantly impact their safety and effectiveness
However, ongoing research and clinical trials continue to investigate their potential role (Mullins et al., 2019)
This is quite normal, and your pulse should settle back into a routine over time
Additionally, because GLP-1s slow down your digestion, the way your body absorbs your medication could change slightly